Myomo (MYO) Cash from Investing Activities (QoQ) (2017 - 2025)
Myomo (MYO) Cash from Investing Activities (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Myomo | 43.43 Mn | 24.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 125.05% |
| Jun 30, 2025 | 60.06% |
| Mar 31, 2025 | -40.12% |
| Dec 31, 2024 | -147.90% |
| Sep 30, 2024 | 21.22% |
| Jun 30, 2024 | 165.79% |
| Mar 31, 2024 | -254.40% |
| Dec 31, 2023 | 274.44% |
| Sep 30, 2023 | 55.62% |
| Jun 30, 2023 | -6,473.38% |
| Mar 31, 2023 | -1,231.91% |
| Dec 31, 2022 | 40.99% |
| Sep 30, 2022 | 89.13% |
| Jun 30, 2022 | 78.79% |
| Mar 31, 2022 | -939.81% |
| Dec 31, 2021 | 56.39% |
| Sep 30, 2021 | 72.98% |
| Jun 30, 2021 | -356.64% |
| Mar 31, 2021 | -187.81% |
| Dec 31, 2020 | 31.04% |